Optimizing Market Access for Medical Devices
MedTech companies dedicate tremendous efforts to demonstrate safety and efficacy of their new technologies to achieve regulatory approval and convince physicians of the value of their innovation. Unfortunately, many companies struggle to win proper coverage, coding and payment for new technologies.
Payers focus on different questions, assuming that safety and efficacy have been already established by the regulatory authorities. Payers assess new technologies with the aim to understand the benefit for the patients and for the healthcare system as a whole. In addition to clinical effectiveness, health economic arguments are often being requested for new technologies. Understanding market access pathways and integrating payers’ considerations early into clinical development programs can help maximizing the return on your clinical investments and speed up the time to reimbursement.
In this webinar, Brigitte Casteels, Executive Advisor, Cytel and Natasha Mühlemann, VP Strategic Consulting, Cytel, reviews the reimbursement landscape and market access strategies for medical device and discusses how to integrate market access considerations into clinical development programs.
Meet the speaker
Brigitte is an acknowledged international business leader who combines strong commercial acumen and extensive field experience in Market Access, Funding and Reimbursement, and Public Affairs for Medical Technology, including medical devices and in vitro diagnostics. Brigitte founded BC Consulting and Solutions in 2011 to deliver personalized, inclusive and international consulting services to the innovative medical technology companies that aim to invest and expand their footprint in Europe.